SCHEMBL2874235

SCHEMBL2874235

COc1ccc(C(=O)Nc2ccccc2C(C)(C)C#N)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.60
CHEK1 O14757 1/20 0.59
PIM1 P11309 1/20 0.59
MAPK8 P45983 1/20 0.59
CLK4 Q9HAZ1 1/20 0.59
ALDH1A1 P00352 1/20 0.56
PKM P14618 1/20 0.56
PDE5A O76074 1/20 0.55
PDE1A P54750 1/20 0.55
PDE1B Q01064 1/20 0.55
PDE1C Q14123 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
POLB P06746 2/20 0.53
KMT2A Q03164 3/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28636074 0.83 PDE4D (0.76) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL30136224 0.83 PDE4D (0.76) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL11244161 0.82 PDE4D (0.81) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL2864733 0.81 PDE4D (0.60) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL2816814 0.81 MAPT (0.54) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL2815613 0.81 NPC1 (0.57) ALDH1A1PKMPOLBKMT2AKDM4E
SCHEMBL2818082 0.80 MAPT (0.53) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL2813529 0.79 MAPT (0.57) PDE4DALDH1A1POLBKMT2AKDM4E
SCHEMBL13576585 0.79 PDE4D (0.76) PDE4DCHEK1PIM1MAPK8CLK4
SCHEMBL2816286 0.79 RAB9A (0.54) ALDH1A1PKMPOLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG PDE4D 366/4885CHEK1 2333/4885PIM1 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.